Amandine G. B.
- Country
- France
- Department
- Infectious and tropical disease
Research Overview
- Comparative Study of Doravirine/Lamivudine Versus Dolutegravir/Lamivudine for Maintenance Therapy in HIV Patients with Suppressed Viral Load
- Evaluation of AZD3152 and Cilgavimab for Pre-exposure Prophylaxis of COVID-19 in Immunocompromised Patients: A Randomized, Double-blind, Phase I/III Study
- Phase 2 Randomized, Open-Label Trial of Intradermal vs. Subcutaneous MVA-BN Vaccine Booster for Mpox Immunogenicity in Previously Vaccinated Individuals
Data & Insights
Has run more than one trial at 8 of 73 partner sites.
Specializations
Infectious Disease Management
This investigator specializes in the clinical research of major infectious diseases, particularly focusing on COVID-19 and HIV treatment and prevention strategies.
- Viral Prevention Research
- Antibody-Based Therapeutics
- Antiviral Treatment Optimization
The investigator evaluates novel prophylactic approaches and treatment regimens for infectious diseases.
COVID-19 Research
The investigator conducts research on pre-exposure prophylaxis utilizing novel antibody treatments, with particular attention to SARS-CoV-2 variants.
- Preventive Medicine
- Novel Antibody Therapies
- Variant-Specific Response
Their work encompasses safety and efficacy evaluations of innovative preventive treatments against COVID-19.
HIV Treatment Studies
The investigator explores antiretroviral therapy optimization, focusing on comparing the effectiveness of different drug regimens for viral load suppression.
- Two-Drug Regimens
- Virological Success Maintenance
- Treatment Simplification
Their research examines the potential of simplified treatment approaches while maintaining therapeutic efficacy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.